JP2001519330A - Hcmv感染の治療に用いるアゼチジノン誘導体 - Google Patents

Hcmv感染の治療に用いるアゼチジノン誘導体

Info

Publication number
JP2001519330A
JP2001519330A JP2000514885A JP2000514885A JP2001519330A JP 2001519330 A JP2001519330 A JP 2001519330A JP 2000514885 A JP2000514885 A JP 2000514885A JP 2000514885 A JP2000514885 A JP 2000514885A JP 2001519330 A JP2001519330 A JP 2001519330A
Authority
JP
Japan
Prior art keywords
lower alkyl
group
phenyl
compound
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2000514885A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001519330A5 (cg-RX-API-DMAC10.html
Inventor
クリスチャン ヨアキム
カセリーヌ チャボ
ロバート デジール
スティーヴン カワイ
ウィリアム ダブリュー オギルヴィー
ジェフリー オメーラ
Original Assignee
ベーリンガー インゲルハイム (カナダ) リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ベーリンガー インゲルハイム (カナダ) リミテッド filed Critical ベーリンガー インゲルハイム (カナダ) リミテッド
Publication of JP2001519330A publication Critical patent/JP2001519330A/ja
Publication of JP2001519330A5 publication Critical patent/JP2001519330A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2000514885A 1997-10-07 1998-10-06 Hcmv感染の治療に用いるアゼチジノン誘導体 Ceased JP2001519330A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6154897P 1997-10-07 1997-10-07
US60/061,548 1997-10-07
PCT/CA1998/000954 WO1999018073A1 (en) 1997-10-07 1998-10-06 Azetidinone derivatives for the treatment of hcmv infections

Publications (2)

Publication Number Publication Date
JP2001519330A true JP2001519330A (ja) 2001-10-23
JP2001519330A5 JP2001519330A5 (cg-RX-API-DMAC10.html) 2006-01-05

Family

ID=22036473

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000514885A Ceased JP2001519330A (ja) 1997-10-07 1998-10-06 Hcmv感染の治療に用いるアゼチジノン誘導体

Country Status (10)

Country Link
US (1) US6211170B1 (cg-RX-API-DMAC10.html)
EP (1) EP1023265B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001519330A (cg-RX-API-DMAC10.html)
AT (1) ATE231124T1 (cg-RX-API-DMAC10.html)
AU (1) AU9426198A (cg-RX-API-DMAC10.html)
CA (1) CA2301967C (cg-RX-API-DMAC10.html)
DE (1) DE69810800T2 (cg-RX-API-DMAC10.html)
DK (1) DK1023265T3 (cg-RX-API-DMAC10.html)
ES (1) ES2187064T3 (cg-RX-API-DMAC10.html)
WO (1) WO1999018073A1 (cg-RX-API-DMAC10.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA91341C2 (ru) 2004-07-15 2010-07-26 Амр Текнолоджи, Інк. Арил- и гетероарилзамещенные тетрагидроизохинолины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина
GB0608899D0 (en) * 2006-05-05 2006-06-14 Leuven K U Res & Dev Novel viral replication inhibitors
ES2428326T3 (es) * 2007-10-04 2013-11-07 Merck Sharp & Dohme Corp. Derivados de aril sulfona sustituida como bloqueadores de canales de calcio
US9156812B2 (en) 2008-06-04 2015-10-13 Bristol-Myers Squibb Company Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
JP5739415B2 (ja) 2009-05-12 2015-06-24 ブリストル−マイヤーズ スクウィブ カンパニー (S)−7−([1,2,4]トリアゾロ[1,5−a]ピリジン−6−イル)−4−(3,4−ジクロロフェニル)−1,2,3,4−テトラヒドロイソキノリンの結晶形態およびその使用
CN102595902B (zh) * 2009-05-12 2015-04-29 阿尔巴尼分子研究公司 7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
ES2446971T3 (es) 2009-05-12 2014-03-11 Albany Molecular Research, Inc. Tetrahidroisoquinolinas sustituidas con arilo, heteroarilo, y heterociclo y su uso
WO2014055644A2 (en) * 2012-10-02 2014-04-10 New York University Pharmaceutical compositions and treatment of genetic diseases associated with nonsense mediated rna decay
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61289074A (ja) * 1985-04-10 1986-12-19 メルク エンド カムパニ− インコ−ポレ−テツド 抗炎症剤および抗変性剤としての新規な置換アゼチジノン類
WO1995025539A1 (en) * 1994-03-23 1995-09-28 Tokyo Tanabe Company Limited Novel remedy for respiratory-tract viral disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229381A (en) 1983-12-01 1993-07-20 Merck & Co., Inc. Substituted azetidinones as anti-inflammatory and antidegenerative agents
NZ228600A (en) * 1988-04-11 1992-02-25 Merck & Co Inc 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives
DE377549T1 (de) 1989-01-03 1990-11-08 Marcos Y. Southbridge Mass. Kleinerman Fernmessung physikalischer variablen mit faseroptischen systemen.
US5104862A (en) 1991-03-20 1992-04-14 Merck & Co., Inc. Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
US5100880A (en) 1991-03-20 1992-03-31 Merck & Co., Inc. Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone
GB2266527A (en) 1992-03-17 1993-11-03 Merck & Co Inc Substituted azetidinones useful in the treatment of leukemia
GB9314350D0 (en) * 1993-07-12 1993-08-25 Zeneca Ltd Armide derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61289074A (ja) * 1985-04-10 1986-12-19 メルク エンド カムパニ− インコ−ポレ−テツド 抗炎症剤および抗変性剤としての新規な置換アゼチジノン類
WO1995025539A1 (en) * 1994-03-23 1995-09-28 Tokyo Tanabe Company Limited Novel remedy for respiratory-tract viral disease

Also Published As

Publication number Publication date
WO1999018073A1 (en) 1999-04-15
AU9426198A (en) 1999-04-27
DE69810800T2 (de) 2003-09-18
DE69810800D1 (de) 2003-02-20
EP1023265A1 (en) 2000-08-02
EP1023265B1 (en) 2003-01-15
CA2301967C (en) 2005-05-17
US6211170B1 (en) 2001-04-03
ATE231124T1 (de) 2003-02-15
ES2187064T3 (es) 2003-05-16
CA2301967A1 (en) 1999-04-15
DK1023265T3 (da) 2003-02-24

Similar Documents

Publication Publication Date Title
EP3121164B1 (en) Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
AU2002219555B2 (en) VLA-4 Inhibitors
EP1308439B1 (en) Proline derivatives and use thereof as drugs
AU2016366310B2 (en) Improved apelin receptor (APJ) agonists and uses thereof
TWI498115B (zh) 咪唑羰基化合物
US6242439B1 (en) Azetidinone derivatives for the treatment of HCMV infections
AU2022275470B2 (en) Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
SG11202107680PA (en) Novel substituted sulfonylurea derivatives
EP0751145A2 (en) HIV-protease inhibitors
JPH0820597A (ja) トロンビン阻害作用を有する複素環カルボニル化合物
EP1023265B1 (en) Azetidinone derivatives for the treatment of hcmv infections
CZ20033325A3 (cs) Deriváty pyrrolidinu jako inhibitory faktoru Xa
US20040009966A1 (en) Interleukin converting enzyme inhibitors
EP0649843B1 (en) Thiazoline derivative
US6222043B1 (en) Methods of preparing novel dipeptide compounds or pharmaceutically acceptable salts thereof
US6239125B1 (en) Azetidinone derivatives for the treatment of HCMV infections
WO2006105386A1 (en) Cdk2 inhibitors
SK3242000A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
JP2001233875A (ja) ピリミジン−5−カルボキサミド化合物、その製造法およびその用途
MXPA00003451A (en) Azetidinone derivatives for the treatment of hcmv infections
MXPA00003441A (en) Azetidinone derivatives for the treatment of hcmv infections
HK40040855A (en) Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives
HK40049106A (en) Sulfonylaminobenzamide derivatives
HK40049106B (en) Sulfonylaminobenzamide derivatives
AU2005229666A1 (en) Nitrogen-containing 5-membered ring compound

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20051005

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090622

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20090729

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20090805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100422

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100722

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20101028

A045 Written measure of dismissal of application [lapsed due to lack of payment]

Free format text: JAPANESE INTERMEDIATE CODE: A045

Effective date: 20110217